Renal transplantation in insulin-dependent diabetic patients. 1974

C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
March 1981, L'union medicale du Canada,
C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
December 2004, Harefuah,
C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
December 1996, Transplantation proceedings,
C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
February 1991, Revista medica de Chile,
C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
July 1973, Lancet (London, England),
C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
March 1977, JAMA,
C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
December 1995, Endocrine journal,
C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
January 1979, Lancet (London, England),
C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
January 1982, Minerva nefrologica,
C M Kjellstrand, and J R Shideman, and R L Simmons, and T J Buselmeier, and B von Hartitzsch, and F C Goetz, and J S Najarian
April 1997, Diabetes research and clinical practice,
Copied contents to your clipboard!